Scalable hybrid synthetic/biocatalytic route to psilocybin

J Fricke, R Kargbo, L Regestein, C Lenz… - … A European Journal, 2020 - Wiley Online Library

Abstract

Psilocybin, the principal indole alkaloid of Psilocybe mushrooms, is currently undergoing clinical trials as a medication against treatment‐resistant depression and major depressive disorder. The psilocybin supply for pharmaceutical purposes is met by synthetic chemistry …

Last updated: Jul 27, 2020